Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MK8245 (8245-004)(COMPLETED) [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluated the safety, tolerability, pharmacokinetics and pharmacodynamics of MK8245 (8245-004) in individuals with Type 2 diabetes mellitus. …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• MK8245 (8245-004) (MK8245)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Type 2 Diabetes | Phase 1 | Status: COMPLETED | Results posted: 2011-01-20